Molecular Diagnostics: New tools for evidence-based medicine

This white paper highlights some of the developments fueling the medical diagnostic (Dx) industry — including accomplishments and promise as well as the challenges facing the sector. The medical diagnostic (Dx) sector is playing a central role in the shifting health care and drug discovery landscape. Energized by the demand for changes in health care and driven by a wave of molecular advances, the Dx sector is responding with innovative new tools and technologies.

 

 

 

 

 

 

 

Molecular Diagnostics: New tools for evidence-based medicine

Download (“pdf”)